To ensure the quality and safety of medical services in primary healthcare institutions, China’s National Health Commission (NHC) and other relevant authorities issued a notice on 1 April 2026, outlining a three-year nationwide action.

Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences. Financial terms of the agreement were not disclosed and are not material to either party.

China Association of In Vitro Diagnostics (CAIVD) and In Vitro Diagnostics Society of China Association for Medical Devices Industry jointly compiled this report.

MGI Tech said last week that its DNBSeq-G99 sequencer has been approved as a medical device by China's National Medical Products Administration (NMPA).

Ibex Medical Analytics (Ibex) has launched a breast cancer biomarker scoring tool powered by artificial intelligence (AI) to help clinicians with treatment decisions.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Paige, a technology disruptor in healthcare, has joined forces with Microsoft in the fight against cancer, making headway in their collaboration to transform cancer diagnosis and patient care by building the world’s largest image-based artificial intelligence (AI) models for digital pathology and oncology.

Novartis subsidiary Navigate Biopharma announced on Friday that it has formed a strategic collaboration with Becton Dickinson to help develop and commercialize companion diagnostics and clinical decision-making tools using flow cytometry.

As a global company with a broad range of businesses, operations in over 160 countries and 115,000 people around the world, diversity is inherent to our business and organization.

Laborie Medical Technologies has entered a definitive agreement for the acquisition of medical device company Urotronic in a deal valued at up to $600m.

On September 6th, Roche Diagnostics China announced its official partnership with Deep Informatics. They will jointly launch a pathology artificial intelligence (AI) assisted interpretation algorithm product, further promoting the digitalization and intelligent transformation of pathology diagnosis in China, providing strong support for the development of personalized precision diagnosis and treatment.